iBio, Inc.IBIONYSE
Loading
Year-over-year total asset growth rate
5Y CAGR
-56.6%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.37% |
| Q3 2025 | 176.71% |
| Q2 2025 | 21.37% |
| Q1 2025 | -11.96% |
| Q4 2024 | -11.50% |
| Q3 2024 | -14.68% |
| Q2 2024 | -42.71% |
| Q1 2024 | 47.42% |
| Q4 2023 | -9.70% |
| Q3 2023 | -8.56% |
| Q2 2023 | -7.16% |
| Q1 2023 | -14.31% |
| Q4 2022 | -38.74% |
| Q3 2022 | -14.93% |
| Q2 2022 | -13.84% |
| Q1 2022 | -8.76% |
| Q4 2021 | -12.03% |
| Q3 2021 | -2.20% |
| Q2 2021 | 2.99% |
| Q1 2021 | -1.86% |
| Q4 2020 | 24.01% |
| Q3 2020 | 24.49% |
| Q2 2020 | 123.09% |
| Q1 2020 | 16.04% |
| Q4 2019 | 3.47% |
| Q3 2019 | 14.97% |
| Q2 2019 | -14.26% |
| Q1 2019 | -11.49% |
| Q4 2018 | -6.04% |
| Q3 2018 | -0.43% |
| Q2 2018 | 38.83% |
| Q1 2018 | -10.92% |
| Q4 2017 | 4.21% |
| Q3 2017 | -7.16% |
| Q2 2017 | -11.52% |
| Q1 2017 | -7.90% |
| Q4 2016 | -8.12% |
| Q3 2016 | -6.80% |
| Q2 2016 | 1.85% |
| Q1 2016 | 438.07% |